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There was in 2019 in the USA alone over 17 000 new cases of spinal cord injury and close 
to 300 000 patients in total. This life-threatening condition isn’t only traumatic and 
devastating for patients and their family, it is as well an enormous financial burden. 
Patients suffering spinal cord injury will lose the ability to move and feel below the level of 
the injury, making them either paraplegic or tetraplegic. Complete lesions, where no tissue 
is spared will impair the patient for life with no chance of recovery without medical 
intervention. Even if incomplete lesions leave the possibility of some level of recovery, the 
path is long and sometimes unsuccessful. This recovery was shown to rely on remodeling 
of cut axons away from the scar tissue in both motor and sensory systems. In order to 
reach recovery, the cut axons will have to sprout and reach a suitable target, that will then 
convey the inputs previously lost. The motor pathways have been studied for decades 
because of their prevalence and importance in injured patients, but always more reports 
inform on the necessity to recover both motor and sensory inputs in order to regain full 
motricity. 
The purpose of this thesis was to look how sensory axons remodel following dorsal column 
lesion and if, like in the motor system, formation of a detour circuit allowed functional 
recovery. 
First, we investigated how DRG axons remodel following dorsal column lesion and 
observed significant increase in DRG sprouting in the grey matter of the spinal cord 3 
weeks after injury persisting at 12 weeks. When we looked at the localization of DRG 
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collaterals, we saw an increase of boutons in the dorsal and ventral layers of the spinal 
cord, leading to the search and discovery of DRG neurons’ target: the cuneate nucleus 
projecting neurons. The study of contacts between DRG and cuneate nucleus projecting 
neurons showed an increase of contacts 3 weeks post lesion of DRG collaterals on 
cuneate nucleus projecting neurons as well as an overall increase of number of contacts 
onto single neurons at both 3 and 12 weeks. 
Then, the characterization of these relay neurons presented new insights on possible 
molecular cues implicated in recovery in sensory tracts as an increase in contact onto 
parvalbumine and glutamate expressing cuneate nucleus neurons was found. 
Finally, study of the spontaneous recovery using behavioral testing showed recovery of 
proprioceptive inputs 3 weeks after dorsal column lesion, validated by a relesion 
experiment. 
To summarize, with this thesis, we aimed to better understand the detour circuit formation 
in the sensory system following dorsal column lesion. The characterization of the relay 





Chapter 1 Introduction 
I. Spinal cord injury (SCI) facts and figures 
A spinal cord injury - damage to any part of the spinal cord or nerves at the end of the 
spinal canal - often causes permanent changes in strength, sensation and other body 
functions below the site of the injury (Mayo Clinic Staff, 2017). Only in Europe, the 
incidence of SCI goes from 5.5 to 195.4 cases per million (Jazayeri et al, 2015). 
Worldwide, it accounts for 23.0 cases per million on average, meaning about 7 500 new 
cases per year (Figure 1). 
 
Figure 1 Annual incidence of spinal cord injury in regions and countries in Europe and the 
Middle East (reprint permission from (Singh et al, 2014)) 
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Most cases of SCI happen in males (78%) with an average age of 43 years old. Vehicle 
accidents and falls are at the moment accounting for 2/3 of the overall causes with 42 and 
23% respectively (Figure 2). 
In addition of being a tremendous change in a person’s life, SCI patients have to deal with 
expensive and long-term costs (health care, living expenses, home upgrade, …). These 
costs highly depend on the severity and level of the injury but as well on the education, 
the pre-injury employment, or the neurological impairment (National Spinal Cord Injury 
Statistical Center, University of Alabama at Birmingham). For example, the first-year 
expenses of a patient suffering from a SCI at cervical level can reach 1,000,000 USD. 
Lifetime costs of such a 25-year-old patient would reach 4,000,000 USD by death time. 
A spinal lesion leads to the loss of motor and sensory functions under the level of the 
injury. Different parameters define the impairment (Kirshblum et al, 2011) : a tetraplegia 
















Etiology of Spinal Cord Injury
Figure 2 Etiology of Spinal Cord Injury (graph of data from National Spinal Cord Injury Statistical 
Center) 
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without legs, arms and torso functions. A paraplegia refers to the loss of input from the 
thoracic, lumbar or sacral level, sparing the arms functions.  A more precise scale has 
been used for years, the ASIA impairment scale (AIS), and defines the degree of 
impairment using five grades (Figure 3). Incomplete tetraplegia is the most occurring (with 
about 47% of the total SCI) followed by complete and incomplete paraplegia (with both 
20% of the occurrence). 
After an incomplete injury some degree of spontaneous recovery can be observed (Burns 
et al, 1997) and allow the patient to regain part of their motor and sensory functions 
(Raineteau & Schwab, 2001). Or the contrary, complete injuries have repercussions on 
the body far greater than the spinal lesion (Castro et al, 2000; Cramer et al, 2005) and 
lead to long term complications such as pressure ulcers or pneumonia (McKinley et al, 
1999). 
Hospitalizations have for the past 10 years greatly decreased due to the advanced of care 
and the causes of death after spinal cord injury have shift from septicemia to circulatory 
causes (Savic et al, 2017; Soden et al, 2000). Nevertheless, respiratory infections 
(pneumonia and bronchopneumonia) are still the main source of death with about 30% of 
the overall causes. 
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II. Spinal cord injury pathophysiology 
During and after spinal cord injury, two phases can be distinguished: the primary and the 
secondary phase (Figure 4).  
The primary phase starts at the moment of the injury itself and include the impact and the 
following compression. The lesion to the spinal cord can result from various causes such 
as an impact, a laceration, a shear, … and involve four mechanisms: impact with 
persistent compression, impact with transient compression, distortion, or laceration 
(Dumont et al, 2001a; Sekhon & Fehlings, 2001). The extent of the primary injury often 
gives a good indication of a patient’s prognostic. The first insult to the spinal cord often 
disrupts only the grey matter (therefore sparing the white matter) and is accompanied by 
Figure 3 ASIA Impairment Scale© 2011 American Spinal Injury Association. Reprinted with 
permission. 
 5 
hemorrhage, disturbing the blood flow inside the entire spinal cord. Neurons that lie within 
the injury suffer as well from the impact and the hemorrhage and are shown to have a 
myelin sheath thinner as neurons outside of the lesion (Blight & Young, 1989).  
The secondary phase occurs minutes to hours after the primary phase and exhibits 
inflammation, cell death, ischemia and release of radicals, among other (Ahuja et al, 2017) 
Because some features can be found in both the primary and secondary phases, three 
stages are describing it more accurately : acute, sub-acute and chronic (Oyinbo, 2011). 
During the acute phase, sign of ischemia, edema or plasma membrane can be seen 
(Paterniti et al, 2009; Simon et al, 2009). These changes happen as well during the sub-
acute phase in addition to nitric oxide excess, demyelination of surviving axons or 
apoptosis (McTigue, 2008; Wu & Ren, 2009). During the chronic phase (that occurs 
months to years after the injury), the existing demyelination and apoptosis continue and 
changes in ion channels are seen, as well as syringomyelia and glial scar formation 





Figure 4 Mechanisms of Spinal Cord Injury: the primary and secondary phase. Reprint 
permission from (Jorgensen et al, 2015) 
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III. Interventions following spinal cord injury 
Because SCI is a multi-phase trauma, different approaches can be taken depending on 
the phase (acute, sub-acute or chronic). 
Right after the injury, one of the interventions is done surgically in order to decompress 
the spinal cord (Fehlings et al, 2012; Li et al, 2014). Surgical decompression might be 
beneficial for recovery if performed in the first 24 hours following injury. Because of the 
impact on the other body’s organs, the other course of treatment focuses on the 
prevention of hypotension and hypoperfusion, both leading to the increase risk of ischemic 
injury (Dumont et al, 2001b). There are as of now, no pharmacological treatments during 
the acute phase, leading to the targeting of biological mechanisms during the sub-acute 
and chronic phase. Nevertheless, the use of corticosteroids has been shown to improve 
the spinal cord oedema during the acute phase. The anti-inflammatory properties of 
methylprednisolone (MP) make it a good candidate for its administration during the acute 
phase even if conflicting results were produced (Hall, 1992, 1993). Tirilazad mesylate (TM) 
was evaluated during the MP trial for its efficacity in the acute phase and showed no 
improvement but was found to protect against the secondary damages. TM functions as 
a threefold agent by scavenging lipid peroxyl radicals, preventing lipid peroxidation and 
stabilizing the membrane, therefore decreasing the membrane fluidity (Hall, 1988), with 
the difference that, compared to MP, TM does not have some of the steroid side effects, 
giving a more cerebroprotective efficacity. 
Several treatment options were studied and show only partial improvement following SCI, 
such as opioid receptors antagonists (Bracken & Holford, 1993; Olsson et al, 1995), 
antioxidants and free radical scavengers (Anderson et al, 1988; Braughler, 1985) or 
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calcium/sodium channels blockers (Fehlings et al, 1989; Stys et al, 1992; Teng & Wrathall, 
1997) 
During the sub-acute and acute phase, treatments tend to focus on the consequences of 
the injury. Autonomic dysreflexia (AD) is considered as one of the main emergency 
following SCI and occurs mostly when the lesion is above thoracic level 6 (Krassioukov et 
al, 2009). Its main characteristics are the elevation of blood pressure, bradycardia, and 
tachycardia. If not treated, AD can lead to cranial hemorrhage (Eltorai et al, 1992; Valles 
et al, 2005), seizures (Yarkony et al, 1986) and death (Dolinak & Balraj, 2007). Because 
AD can be triggered through a common stimulus (irritation to the bladder or colon), efforts 
are made on preventing it, either surgically or through medication. Botulinum toxin was 
found to decrease urethral pressure and permitted 6 weeks post treatment to recover 
continence for 90% of the patients (Dykstra et al, 1988; Huang et al, 2016; Schurch et al, 
2000). 
Long term care of patients suffering from SCI is as well dealing with depression or pain. 
Depending on various factors (age, sex, demographic, severity of the injury), depression 
is shown to affect 1 out of 5 patients and tend to exacerbate lower functional 
independence and secondary complications (Kalpakjian et al, 2009; Khazaeipour et al, 
2015). Patients benefit from physical exercise, psychological help and when necessary, 
antidepressants (Fann et al, 2015; Fann et al, 2013). 
Dealing with chronic pain is a challenge for care takers because of the variety and severity 
of pain (Masri & Keller, 2012; Siddall & Loeser, 2001). Depending on the type of injury 
(complete or incomplete), patients will suffer differently. An incomplete lesion will lead to 
muscle spasms, whereas a complete lesion will trigger central dysesthesia syndrome, 
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more commonly known as phantom pain. This syndrome is the most difficult type of pain 
to manage because of the wide range of symptoms, sometimes impossible to precisely 
describe. This pain is poorly understood and badly respond to medication. Multiple clinical 
trials have been conducted to deal with chronic pain, improving patient’s life (Cardenas & 
Jensen, 2006; Finnerup et al, 2002). 
During the acute phase, efforts are made to help the patient have some level of recovery 
below the injury. One main strategy is locomotor training (Behrman & Harkema, 2000; 
Hubli & Dietz, 2013; Nas et al, 2015). Modern strategies do not only try to compensate 
the disabilities but look at the functional recovery of patients, therefore aiming at neuronal 
repair and plasticity. Depending on the ASIA score of the patient, different strategies are 
used. When the injury is below cervical level 8, patients are independent for daily activities, 
therefore, locomotor training will focus on muscle strengthening, standing and stepping 
activities. Studies in rats and mice show that treadmill and voluntary training improved 
motor recovery (Goldshmit et al, 2008; Heng & de Leon, 2009; Loy et al, 2018). For a 
patient suffering from quadriplegia, other approaches are taken, as only a few body 
functions are spared. The use of robotic has become more and more prominent in the 
past 10 years and show promising results (Edgerton & Roy, 2009; Hornby et al, 2005; 
Louie et al, 2015; Yozbatiran et al, 2012). 
Studies show that following SCI a great decrease in spinal cord, white matter and 
corticospinal tract volume occur within 2 years post injury (Faden et al, 2016; Ziegler et 
al, 2018). These decreases are irreversible and exacerbate the necessity to study and 
improve SCI outcomes. 
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IV. Spinal cord injury models 
In order to understand SCI mechanisms, researchers developed animal models to mimic 
the injury and the following biological cascades. Several animals are used, rats primarily 
(about 72%), followed by mice (16%). Primates and other mammalians, mimicking more 
closely human SCI, are used in only 7% of the studies because of the relative high costs 
and ethical consideration (Sharif-Alhoseini et al, 2017). 
There are three main type of injury model, each one trying to recreate as closely as 
possible the human SCI. 
1. The contusion models 
This model is being used in about 43% of the studies and was invented in 1911 by Alfred 
Allen. He used an impactor where a weight was dropped on an open spinal cord and 
studied the optimal weight and distance from the cord to recover its functions (Allen, 
1911). Since 1911, other contusion apparatuses were invented such as electromagnetic 
impactors or air gun devices.  
The aim of a contusion model is mainly the study of physiopathological changes because 
during and after SCI, patients suffer from compression and/or contusion (Chang, 2007). 
The advantage of this technique is the ability to choose the severity of the injury depending 
on the power of the impact (Figure 5). 
Many studies have been conducted using the contusion model to look at the glial scar 
(Brambilla et al, 2005; Iaci et al, 2007; Zhang et al, 2011), to transplant cells (Martin et al, 
1996; Tetzlaff et al, 2011) or to analyze behavior (Gensel et al, 2006; Hamers et al, 2001; 
Ma et al, 2001). 
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2. The compression models 
This model is being used in about 20% of the studies and has the advantage to mimic the 
human SCI compression and optimal decompression time (Rivlin & Tator, 1978). It 
enables to cause ischemia and most common clinical injuries. Some apparatus, like the 
balloon allow to damage the spinal cord in specific area without affecting the surrounding 
structures (Lim et al, 2007; Vanicky et al, 2001).  
Studies using the compression model look at post injury treatments and decompression 
time in order to improve post lesion care (Fehlings & Perrin, 2005; Guha et al, 1987). They 
Figure 5 Spinal cord cross-sections from laminectomy controls, and the 4 groups of 
contused mice at the injury epicenter of the lesion, taken 28 days after surgery. Reprint 
permission from (Ghasemlou et al., 2005) 
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analyze protein expression as well following injury in order to improve neurological 
outcome (Curtis et al, 1993; Hamada et al, 1996; Li et al, 1996; Saadoun et al, 2008). 
3. The transection models 
The transection model is the second most used animal model in SCI research. The lesion 
will be made using iridectomy scissors, allowing a precise and reproducible injury. About 
34% of the studies use it and is separated in two groups: complete and incomplete injuries 
(Figure 6). A complete injury will cut completely the connection between the brain and the 
lower spinal cord (Courtine et al, 2009; Lavrov et al, 2006). An incomplete injury will 
selectively interrupt a specific pathway or tract, allowing the study of specific mechanisms 
(Bareyre et al, 2004; Kim et al, 2004; Lavrov et al., 2006; Rosenzweig et al, 2010). The 
interrupted tract can either be a descending/motor tract (Hains et al, 2003; Rosenzweig et 
al., 2010; Sasaki et al, 2006), or an ascending/sensory tract (Blesch & Tuszynski, 2003; 
Inman & Steward, 2003). 
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Transection models are particularly good to study bioscaffolds, effect of neurotrophic 
factors on the scar, neuroplasticity or regeneration (Edgerton et al, 2004; Gros et al, 2010; 
Liu et al, 2012; Schwab & Bartholdi, 1996). 
V. Remodeling after SCI 
1. Spontaneous regeneration  
It has been known for decades that cut axons will not regrow through the lesion scar. But 
after being carefully studied, it was shown that even the adult CNS can remodel, avoiding 
Figure 6 Diagram of different mid-thoracic penetrating SCI lesions. Coronal and sagittal 
views of the injury site after dorsal hemisection (A), complete transection (B) and a dorsal column 
lesion (C). After tracers (red) are injected into the cortex (for dorsal hemisection and complete 
transection) or into the peripheral nerve (for dorsal column lesion), the traced axons typically fail 
to regenerate across the lesion and are absent from the other side of the spinal cord. Green 
denotes spared axons that are not labeled by the tracer and intentionally left intact. Reprint 
permission from Lee, 2013 
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the injury site. The first studies corroborating this theory were done in 1981 and used 
peripheral nerve graft (David & Aguayo, 1981). Two decades were needed to see the 
same phenomenon in rodent and showed some level of spontaneous recovery as early 
as four weeks post lesion (Fouad et al, 2001). In adults, the same conclusions could be 
drawn and opened a new therapeutic window for patients with incomplete spinal cord 
injury (Burns et al., 1997; Curt et al, 2004). 
Following these findings, research was done looking more closely at ascending and 
descending tracts that were damaged after the injury. One main example is the 
corticospinal tract (CST), one of the major descending motor tracts of the spinal cord 
(Bareyre et al., 2004; Fouad et al., 2001; Lang et al, 2012). Other tracts have been studied 
and show as well spontaneous recovery (Granier et al., 2020; Wang et al, 2011). 
2. The detour circuit paradigm 
Knowing that axons could not regrow through the lesion and scar tissue, one of the main 
questions of this spontaneous recovery was how axons could reconnect with such distant 
targets. Fouad et al. first found that the CST could form new collaterals in the cervical 
region of the spinal cord (Fouad et al., 2001). Bareyre et al. showed that following 
corticospinal tract lesion, the transected neurons will spread new collaterals in the spinal 
cord (where there is no lesion) and contact interneurons known as long propriospinal 
neurons (LPSN). These LPSN will then extend their axons to the lumbar region where 
they will contact motor neurons therefore creating a detour circuit (Bareyre et al., 2004; 
Jacobi & Bareyre, 2015) (Figure 7). 
This new circuit will allow to reroute the motor input as early as 3 weeks post injury and 
was shown to be dependent of different factors such as FGF22 and STAT3 (Jacobi et al, 
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2015; Lang et al, 2013). It should be noted that motor recovery does not happen alone: 
without sensory inputs, motor recovery will only be partial. Differing from motor recovery, 
sensory remodeling hasn’t been that extensively studied mostly because of the lack of 
reliable model but as well due to lack of proper labeling. Hollis et al. showed reorganization 
of proprioceptive tracts and observed new neuronal connections in the dorsal column 
allowing some level of recovery (Hollis et al, 2015). 
3. The somatosensory system 
As previously stated, the recovery of the sensory/somatosensory system hasn’t been 
much studied but is necessary for proper motor recovery. To successfully understand this 
system, one needs to look more into detail how sensory inputs are processed from the 
spinal cord to the brain. 
a. The dorsal column 
Figure 7 Schematic representation of the formation and the regulation of intraspinal detour 
circuits following spinal cord injury. Intraspinal detour circuit formation: Following thoracic 
hemisection, the hindlimb corticospinal tract sprouts collaterals into the cervical spinal cord. 
Those collaterals form synapses with long propriospinal neurons which in turn increase their 
contacts onto lumbar motoneurons thereby forming a new detour pathway that reconnects upper 
corticospinal projection neurons to lumbar motoneurons. Reprint from (Jacobi & Bareyre, 2015)  
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Also known as dorsal medial lemniscus pathway, this tract is responsible for fine touch, 
proprioception and vibration sensation from the entire human body. This tract begins in 
the spinal cord, more specifically in dorsal root ganglions (DRGs), travels in the dorsal 
column and finishes in one of the nuclei of the brainstem (Figure 8). Fibers ascending 
from the sacral, lumbar and lower thoracic segment of the spinal cord end in the gracile 
Figure 8 Sensory information from the limbs and trunk is conveyed to the thalamus and 
cerebral cortex by two ascending pathways (Reproduced by Kandel et al., 2013) Copyright © 
The McGraw-Hill Companies) 
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fascicle, fibers from the upper thoracic and cervical in the cuneate fascicle (Kandel et al, 
2000). This pathway is composed of three orders of neurons: the first order with their cell 
body in the DRG, project to the medulla oblongata second order neurons (either to the 
dorsal, gracile or cuneate nucleus). These neurons then project to third order neurons in 
the thalamus. Inputs arriving in the thalamus are then processed by the primary sensory 
cortex. 
Neurons of the DRG receive their signal from two types of receptors from the skin, 
mechanoreceptors responsible for tactile inputs and proprioceptive receptors (Al-Chalabi 
et al, 2020). It should be noted that even if both proprioception and tactile axons run in the 
dorsal column, they remain separated. The proprioceptive run more ventrally whereas the 
tactile axons run dorsally. Following an incomplete spinal cord injury, it should be known 
how deep the somatosensory lesion is in order to draw proper conclusions concerning the 
detour circuit formation. 
4. Tracing methods to follow remodeling 
Following a dorsal column lesion, the DRG axons will be cut and will not be able to send 
sensory input to the cuneate nucleus anymore. The connection between DRG and first 
order neurons will be interrupted. To follow both parts of the circuit, two specific tracers 
are needed. One anterograde tracer to label DRG neurons and the possible collaterals, 
one retrograde tracer to label first order neurons and any interneurons projecting to the 
cuneate nucleus (in the hypothesis of detour circuit formation). 
Adeno-associated viruses (AAV) is a viral vector that can be specifically engineered and 
used in a wide variety of gene therapy. It has unique biophysical and biological properties 
that make it interesting both in preclinical and clinical research (Naso et al, 2017). It has 
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the ability to deliver inside a host cell different nucleic acid cargo that can be design for 
one’s purpose, labeling neurons, axons and dendrites for example. There are different 
AAV variants, each being able to infect a specific cell type. An AAV9 will be for example 
able to cross the blood brain barrier whereas an AAV8 will be more specific for liver 
delivery (Kattenhorn et al, 2016). For the past ten years. AAV have been used as tracers 
for preclinical research in diverse applications (Cameron et al, 2020; Iwakura et al, 2005; 
Smith & Chauhan, 2018). One advantage and disadvantage of AAV is their inability to 
jump synapses. On one side, it allows tracing of one target and on another side, it restrict 
their use once interneurons are in play. 
In order to label these interneurons, the use of mono-trans-synaptic tracers is necessary.  
Rabies viruses travel in neurons retrogradely through multiple synapses. Because of their 
high efficiency and their ability to jump multiple synapses, new mutants were developed. 
Mebatsion et al. described a rabies variant lacking the envelope glycoprotein (Mebatsion 
et al, 1996). In this mutant, the glycoprotein gene is replaced by a fluorescent protein, 
making it a valuable tracer for mono-trans-synaptic labeling. This rabies virus will be able 
to infect starter cells with high efficiency and can then only infect second degree neurons 
once complemented with its glycoprotein. Once in the second-degree neurons, the virus 
will not be able to spread further, being therefore a great tool to label first order 
connections. 
5. Behavioral tests to assess recovery 
In the motor system, behavioral testing has been done to look at recovery (Courtine et al., 
2009; Goldshmit et al., 2008; Loy et al., 2018). It includes treadmill, where the mouse is 
place on a running treadmill and captors follow hindlimb movement and the ladder rung, 
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where the mouse walks on a regular or irregular ladder and counts are being made when 
it falls (Metz & Whishaw, 2009). Nevertheless, these tests aren’t useful in the sensory 
system. Therefore, proprioceptive, and sensory behavioral tests are required (Shelton et 
al., 2008). Shelton et al. described experiments that allowed to look at different 
parameters: proprioception, coordination, or even sensory input (Figure 9) 
DRG neurons can be divided into three groups depending on their modality: they can be 
responsible for nociception, mechanoreception or proprioception (Marmigere & Ernfors, 
2007). It is as well-known that following spinal cord injury, patients experience phantom 
pain triggered by nociceptive receptors (Kuffler, 2018). It is therefore important to look as 
well at pain response following dorsal column lesion. Different tests have been established 
with the von Frey test being the most popular (Deuis et al., 2017). In this test, the rodent 
Figure 9 Individual SNAP tests. (A) Interactions. (B) Cage grasp. (C) Visual placing. (D) 
Pacing/circling. (E) Gait/posture. (F) Head tilt. (G) Visual field. (H) Baton. Reprint permission from 
(Shelton et al, 2008) 
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is placed in a closed cage with a mesh floor, a single filament is perpendicularly applied 
to the plantar surface of the hind paw and left until the paw buckles (Figure 10A). The 
response time is then used as readout. Others, such as the tail flick test have been used 
in smaller settings to decrease the financial cost of such tests. 
 
  
Figure 10 Methods used to assess mechanically evoked pain like behaviors in rodents. (A) 
Manual Von Frey. (B) Electronic von Frey (MouseMet, TopCat Metrology). (C) Randall-Selitto test 
(handheld device). Open Access (Deuis et al, 2017) 
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Chapter 2 Aim of the study 
The aim of this thesis was to determine whether plasticity and the formation of detour 
circuits, like already shown in the motor system, also exist in the sensory system after a 
dorsal column lesion in mice. 
After spinal cord injury are DRG neurons remodeling and is this remodeling targeting 
specific layers of the spinal cord? 
Bareyre et al. (2004) and Jacobi et al. (2015) showed that following spinal cord injury, the 
CST is able to remodel via LPSN to contact motor neurons in the lumbar region of the 
spinal cord. It was shown that other tracts remodel following injury. Therefore, the first 
process to investigate is the change in sprouting of DRG neurons after dorsal column 
lesion. After lesion, neurons will be traced using an AAV labeled with a EGFP protein and 
looked at two time points: 3 and 12 weeks. It has been shown that after 3 weeks, the first 
valuable connections are being made and after 12 weeks, aberrant connections are lost 
making the mature detour circuit. 
a. What are the targets of this new sprouting and what can we learn about them? 
In the motor system, LPSN are contacted by CST collaterals to form the detour circuit 
(Bareyre et al., 2004; Jacobi & Bareyre, 2015). We investigated which neurons were 
targeted by this increasing DRG sprouting and if the localization of contacts corroborated 
with the collaterals’ varicosities. Characterization of these relay neurons was performed 
using transgenic mice and immunohistochemistry techniques to assess for the neuronal 
population primarily targeted by DRG collaterals. After lesion, DRG neurons were labeled 
using an AAV-EYFP and cuneate nucleus projecting neurons using a pseudotyped rabies 
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virus complemented with its glycoprotein. Spinal cords were stained for different 
neurotransmitters, both inhibitory and excitatory. 
b. Does formation of a detour circuit in the sensory system triggers functional recovery? 
Hollis et al. showed functional recovery following sensory lesion in rats (Hollis et al., 2015) 
and linked it to remodeling of DRG neurons through the dorsal lemniscal pathway. We 
investigated behavioral improvement following dorsal column lesion using the forelimb 
placing and the baton tests (Shelton et al., 2008) as well as the response to a pain test. 
Mice underwent testing prior to injury and every week after injury up to 12 weeks. 
Following full recovery, the dorsal column was lesioned again in order to conclude on the 
implication of the detour circuit formation on functional recovery. 
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Chapter 3 Materials & Methods 
I. Materials 
1. Surgery 
a. Anesthesia and pain medication 
Midazolam-ratiopharm 15mg/3mL Ratiopharm GmbH, Ulm, Germany 
Cepetor® 1mg/mL (Medetomidin) CP-Pharma Handelsgesellschaft mbH, 
Burgdorf, Germany 
Fentanyl-Janssen 0.1mg Janssen-Cilag GmbH, Neuss, Germany 
Ketamine 10% Wirtschaftsgenossenschaft deutscher 
Tierärzte eG, Garbsen, Germany 
Xylasin 2% Bernburg Serunwerk, Bernburg, Germany 
Revertor® 5mg/mL (Atipamezol) CP-Pharma Handelsgesellschaft mbH, 
Burgdorf, Germany 
Flumazenil HEXAL® 0.1mg/mL Hexal AG, Holzkirchen, Germany 
Naloxon-ratiopharm 0.4mg/mL Ratiopharm GmbH, Ulm, Germany 
Metacam Boehringer Ingelheim International 
GmbH, Ingelheim, Germany 
Temgesic Merk&Co, Kenilworth, USA 
 
b. Reagents 
Panthenol-Augensalbe 5g Bayer Vital GmbH, Leverkusen, 
Germany 
Xylocain Gel 2% AstraZeneca GmbH, Wedel, Germany 
Isotonische Natriumchlorid 0.9% Berlin-Chemie Menarini, Berlin, 
Germany 
Ethanol  80% CLN GmbH Chemikalien Laborbedarf, 
Niederhummel, Germany 
 
c. Tools and materials 
Wella contura  Wella, Darmstadt, Germany 
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Noyes Spring Scissors Fine Science Tools GmbH, Heidelberg, 
Germany 
Dumont #5 – Fine Forceps Fine Science Tools GmbH, Heidelberg, 
Germany 
Dumont #3 Forceps Fine Science Tools GmbH, Heidelberg, 
Germany 
Olsen-Hegar Needle Holder Fine Science Tools GmbH, Heidelberg, 
Germany 
Friedman Pearson Rongeur Fine Science Tools GmbH, Heidelberg, 
Germany 
Vannas Spring Scissors Fine Science Tools GmbH, Heidelberg, 
Germany 
Plastipak Hypodermic Syringe 1mL Becton, Dickinson and Company, 
Franklin Lakes, USA 
Sterican Insulin G30 x ½” B. Braun Melsungen AG, Melsungen, 
Germany 
Hypodermic Needles BD Microlance 3 23G x 
1 ¼” 
Becton, Dickinson and Company, 
Franklin Lakes, USA 
Metal Plate Custom-made 
Aluminium Short Fixator Fine Science Tools GmbH, Heidelberg, 
Germany 
Stainless Steel Retractor Wires Fine Science Tools GmbH, Heidelberg, 
Germany 
Stainless Steel Blunt Retractors Fine Science Tools GmbH, Heidelberg, 
Germany 
Sugi Kettenbach GmbH & Co. KG, 
Eschenburg, Germany 
Ethilon Suture 6-0, 667H Johnson & Johnson Medical GmbH, 
Norderstedt, Germany 
Micropipettes/Capillaries 5µL Brand GmbH&Co, Wertheim, Germany 
 
d. Devices 
Olympus KL 1500 LCD Olympus Deutschland GmbH, 
Hamburg, Germany 
Olympus Stereo Microscope SZ51 Olympus Deutschland GmbH, 
Hamburg, Germany 
T/Pump Heating pad Gaymar Industries, Orchard Park (New 
York), USA 
Leica Stereo Microscope M80 Leica Biosystems Nussloch GmbH, 
Nussloch, Germany 
Leica KL 1500 LCD plus Leica Biosystems Nussloch GmbH, 
Nussloch, Germany 





IP high precision multichannel pump Cole-Parmer GmbH, Wertheim, 
Germany 
Digital Scale EK-2000i A&D, San Jose, USA 
Tolloader balance Kern EW (precision scale) Sigma-Aldrich, Merck KGaA, 
Darmstadt, Germany 
FiveEasy Plus pH/mV (pHmeter) Mettler-Toledo GmbH, Gießen, 
Germany 
Hotplate Magnetic Stirrer L-82 Labinco BV, Breda, The Netherlands 
 
b. Tools 
Pipettes, pipette tips and tubes Eppendorf AG, Hamburg, Germany 
Tubes (15 and 50mL) Corning, New York, USA 




PBS 20x (phosphate buffer saline) pH=7.2 5,2 g NaH2PO4 · H2O 
28,8g Na2 HPO4· 2H2O 
175g NaCl (Merck) 
1L dH2O 
Sodium Phosphate Monobasic  27,6 g NaH2PO4xH2O 
Sodium Phosphate Dibasic  35,6 g Na2HPO4x2H2O 
0,5M PB (phosphate buffer) 700mL hH2O 
57mL sodium phosphate monobasic  
243mL sodium phosphate dibasic 
PFA (paraformaldehyde) 4% 40g PFA (Sigma-Aldrich) 
500mL 0,2M PB 





Leica CM1850 Cryostat Leica Biosystems Nussloch GmbH, 
Nussloch, Germany 
Vortex V-1 plus Biosan SIA Medical-Biological Research 
& Technology, Riga, Lettland 




Microscope slide Gerhard Menzel B.V$Co.KG, 
Braunschweig, Germany 
Microscope cover slip 24x32mm Gerhard Menzel B.V$Co.KG, 
Braunschweig, Germany 
Microscope cover slip 25x50mm Gerhard Menzel B.V$Co.KG, 
Braunschweig, Germany 
Laboratory Film PM-996 Sigma-Aldrich, Merck KGaA, 
Darmstadt, Germany 
6, 12 and 24-wells cell culture plates VWR Corporate , Radnor, USA 
Tissue-Tek Cryomold® 25x20x5mm Sakura Finetek Europe B.V., AJ Alphen 
aan den Rijn, The Netherlands 
Tissue-Tek Cryomold® 15x15x5mm Sakura Finetek Europe B.V., AJ Alphen 
aan den Rijn, The Netherlands 
Tissue-Tek Cryomold® 10x10x5mm Sakura Finetek Europe B.V., AJ Alphen 
aan den Rijn, The Netherlands 
 
c. Reagents 
Sucrose Sigma-Aldrich, Merck KGaA, 
Darmstadt, Germany 
Triton X-100 Sigma-Aldrich, Merck KGaA, 
Darmstadt, Germany 
Goat Serum Invitrogen GmbH, Darmstadt, Germany 
Donkey Serum Invitrogen GmbH, Darmstadt, Germany 
Tissue Tek Optimal cutting Temperature Sakura Finetek Europe B.V., AJ Alphen 
aan den Rijn, The Netherlands 
Vectashield Vector Laboratories, Burlingame, USA 
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d. Tracers and antibodies 
 
4. Counting and Imaging 
a. Counting device 
Olympus IX71 inverted fluorescence 
microscope 
Olympus GmbH, Hamburg, Germany 
Objectives: x4/0.13, x10/0.4 air objectives Olympus GmbH, Hamburg, Germany 
 
b. Imaging devices 
FV1000 confocal system mounted on an 
upright BX61 microscope 
Olympus GmbH, Hamburg, Germany 
Objectives: x4/0.13, x10/0.4,x20/0.85 air 
objectives; x25/1.05 water immersion 
objective; x40/0.85, x60/1.42 oil immersion 
objectives 
Olympus GmbH, Hamburg, Germany 
Rabies virus SAG ∆G mcherry 
 
Provided by Karl-Klaus Conzelmann, 




rAAV-CMV-ECFP-ires-Gprotein Custom made 
Polyclonal rabbit anti-Calcitonin Gene Related 
Peptide 
Sigma-Aldrich, Merck KGaA, Darmstadt, 
Germany 
Monoclonal mouse anti-Parvalbumin Swant®, Marly, Switzerland 
Polyclonal rabbit anti-Glutaminase Abcam plc, Cambridge, UK 
Polyclonal rabbit anti-RFP Abcam plc, Cambridge, UK 
Polyclonal chicken anti-GFP Abcam plc, Cambridge, UK 
Goat anti-rabbit (H+L) Alexa fluor® 488 Abcam plc, Cambridge, UK 
Goat anti-rabbit (H+L) Alexa fluor® 594 Invitrogen GmbH, Darmstadt, Germany 
Goat anti-rabbit IgG (H+L) Alexa fluor® 647 Invitrogen GmbH, Darmstadt, Germany 
Goat anti-mouse IgG (H+L) Alexa fluor®647 Invitrogen GmbH, Darmstadt, Germany 
Neurotrace 435/455 blue fluorescent Nissl 
stain 
Invitrogen GmbH, Darmstadt, Germany 
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Leica SP8 Malpighi confocal microscope Leica Microsystems GmbH, Wetzlar, 
Germany 
Leica DM4 upright microscope Leica Microsystems GmbH, Wetzlar, 
Germany 
Objectives: x20/1.0 water immersion 
objective; x40/0.75, x63/1.40 oil immersion 
objectives 




a. Data analysis 
Microsoft Office (PowerPoint, Excel, Word) Microsoft Corporation, Redmond, 
Washington, USA 
ImageJ General Public License 
http://rsbweb.nih.gov/ij/download.html 
Adobe Creative Suite CS6 (Photoshop, 
Illustrator) 




1. Mice and anesthetics 
All animal procedures were performed according to institutional guidelines and were 
approved by the local regulatory authorities. Mice were maintained on a 12 h light/ 12 h 
dark cycle with food and water ad libitum. 
Adults C57Bl6j, GlyT2-EGFP and GAD67-EGFP (kind gift from Prof. Dr. Arthur Konnerth) 
mice, 6 to 20 weeks old, were used for this study. To characterize the subtype of the relay 
neurons, GlyT2 and GAD67 mice, expressing EGFP protein in glycinergic and GABAergic 
cell, respectively, were used. Unlesioned animals served as controls. 
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2. Viruses design and production 
To generate rAAV-CAG-EYFP, pAAV-CAG-EYFP was created by inserting Enhanced 
Yellow Fluorescent Protein (EYFP) from pEYFP-N1 into pAAV-CAG-MCS.  
pAAV-CAG-ECFP-T2A-G (rAAV-G) was created by inserting ECFP-T2A-G between the 
EcoRI and HindIII cloning site of pAAV-CAG-MCS. Briefly, ECFP-T2A-G was first PCR-
cloned from pAAV-CAG-ECFP onto which the T2A sequence was added using the 
following forward primer 5’ CGCCCA GAATTC ATG GTG AGC AAG GGC GAG GAG 
CTG TTC 3‘ and reverse primer 5’ CAC GTC ACC GCA TGT TAG AAG ACT TCC TCT 
GCC CTC TCC GGA TCC CTT GTA CAG CTC GTC CAT GCC GAG AGT 3‘. Then, the 
G envelope protein sequence was PCRed from pCag-GS-CVS-G using as forward primer 
GAG GGC AGA GGA AGT CTT CTA ACA TGC GGT GAC GTG GAG GAG AAT CCC 
GGC CCT ATG GTT CCT CAG GTT CTT TTG TTT GTA and as reverse primer GGG 
CCC AAG CTT CTA GCT TAC AGT CTG ATC TCA CCT CCA.  and ligated to the ECFP-
T2A fragment. Recombinant AAV chimeric virions containing a 1:1 ratio of AAV1 and 
AAV2 capsid proteins and the foreign gene were generated as previously described 
(Grimm & Kay, 2003; Jacobi et al., 2015; Klugmann et al, 2005; Lang et al., 2013). 
Cuneate nucleus projecting neurons were labeled by retrograde monosynaptic tracing 
with a modified rabies virus (SAD-ΔG-RABV) expression the mcherry fluorescence where 
mcherry is expressed instead of their own envelope glycoprotein (G). Mono transsynaptic 




3. Surgical procedures 
a. Cervical dorsal column lesion 
Surgeries were performed under constant anesthesia with either a mixture of Ketamine 
(87 mg.kg-1) and Xylasin (13 mg.kg-1) or a mixture of Midazolam (5.0 mg.kg-1), 
Medetomidin (0.5 mg.kg-1) and Fentanyl (0.05 mg.kg-1).  
After anesthesia, mice were subjected to a laminectomy in order to expose the dorsal 
region of the spinal cord at cervical level 2 (C2). A unilateral dorsal hemisection was 
performed leading to the unilateral transection of the dorsal column, using fine iridectomy 
scissors and leaving intact all other tracts. Following surgery, an antagonist of MMF 
composed of a mixture of Atipamezol (2.5 mg.kg-1), Flumazenil (0.5 mg.kg-1) und Naloxon 
(1.2 mg.kg-1) was subcutaneously injected and an analgesic (Metacam; Boehringer 
Ingelheim) was orally administered twice a day for 24h. Mice were kept on a heating pad 
at 38°C until fully awake. 
b. Relesion of the dorsal column 
Validation of the formation of the detour circuit was assessed using a relesion of the dorsal 
column 12 weeks after the first C2 lesion. After anesthesia, mice were subjected to a 
laminectomy in order to expose the dorsal region of the spinal cord at cervical level 4 (C4). 
A unilateral dorsal hemisection was performed leading to the unilateral transection of the 
dorsal column, using fine iridectomy scissors and leaving intact all other tracts. 
c. Injections of rAAV and SAD-ΔG-RABV 
Control, 3 weeks, and 12 weeks remodeling experiments 
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All viral injections were performed 10 days prior to sacrifice. To label DRG axons we 
pressure injected 0.5µL of rAAV-EYFP (concentration of 5.1011 genome copies/mL) into 
the DRG at cervical level 6 (C6) using a finely pulled glass micropipette (coordinate from 
DRG surface 0.3mm depth). To visualize the injection, a blue dye was added to the rAAV. 
The micropipette was left in place for three minutes following the injection to avoid 
backflow. To label cuneate nucleus projecting neurons, a 1:1 mixture of SAD-ΔG-RABV 
and rAAV-CAG-G (concentration matched to 5.105 and 1,5.1010 genome copies/mL 
respectively) was injected into the cuneate nucleus. In brief, the mouse was place on its 
back and held in place, a fine incision (10 mm long) was done under the jar to access the 
medulla oblongata ventrally, holding the trachea on the side using retractors. Once the 
medulla oblongata was exposed, the central vessel was used as a zero. Then, 0.25µL 
RABV and rAAV mixture was pressure-injected using a finely pulled glass micropipette 
(coordinate from central vessel: 0.2 mm, 0.9 lateral, 2.0 depth). After completing the 
injection, the micropipette was left in place for five minutes. Following surgery an analgesic 
(Metacam; Boehringer Ingelheim) was orally administered twice a day for 24h, 1000 µl 
0,9% Saline solution (B.Braun Melsungen AG) was subcutaneously injected as 
rehydration and the mice were kept on a heating pad at 38°C until fully awake. 
 
4. Tissue processing and immunohistochemistry 
Mice were deeply anesthetized using isoflurane and perfused transcardially with 4% 
paraformaldehyde (PFA) in 0.1M phosphate buffer (Hornby et al.). Brains, spinal cord and 
injected DRG were then microdissected and post fixed overnight in 4% PFA. The tissue 
was cryoprotected in 30% sucrose up to 48h. Using a cryostat, 50 µm thickness sections 
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were cut (longitudinal sections for basic neuroanatomy of the ascending DRG system and 
the DRG sprouting, coronal sections for all other analysis). For the analysis of the tract 
organization, the DRG sprouting, the DRG axons localization, the cuneate nucleus 
projecting neurons localization, the number of contacted neurons and number of contacts 
onto single neurons, a counterstaining was performed with NeuroTrace 435/455 and 
sections were mounted in Vectashield (Vector Laboratories).  
To visualize CGRP and PV expressing neurons, immunohistochemical staining was 
performed on C57/Bl6, GlyT2 and GAD67 mice, as follows: Half of the wells and slides 
per animal were used for the histological analysis, while the rest were kept at 4°C for wells 
with 0.01% PBS-azide and -20°C for slides. The first day sections were washed three 
times in Phosphate-buffered saline (1xPBS) of ten minutes intervals and incubated for 1h 
in a blocking PBS-based solution with 0.5% Triton X-100 and 10% goat-serum (GS). 
Slices were then incubated at 4°C in a PBS-based solution containing primary antibody 
against CGRP or PV, 0.3% Triton X-100 and 2.5% GS, for two overnights. The third day 
and after three ten-minutes intervals washing in 1xPBS, sections were incubated 
overnight at 4°C with the respective secondary antibody (AF647) and NeuroTrace 
435/455 diluted in 1XPBS with 1% GS. Finally, tissue was washed three times at 15 to 20 
minutes intervals to minimize background noise, mounted with Vectashield (Vector 
Laboratories) and stored at -20°C. To visualize glutamatergic neurons antigen retrieval 
was performed prior to the staining. Because antigen retrieval diminishes all signal 
including the yellow and red fluorescence from the injected EYFP and mCherry viruses, 
antibodies against GFP and RFP were used, allowing this method to be performed only 
on C57/Bl6 mice lacking transgenic GFP signal. Heat-mediated antigen retrieval was 
carried out as described: Citrate buffer was prepared by adding and mixing 2,94g of Tri-
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Sodium citrate (Sigma) with 1L distilled water for a final concentration of 10mM. pH was 
adjusted to 8.5 by adding drops of 1M HCl or 1M NAOH. 
Appropriate amount of citrate buffer, according to the number of wells, was heated to 85°C 
and 500ul were distributed immediately in each well. The well plate was carefully sealed, 
top and sides, with 3 layers of parafilm. Tissue was incubated with the heated buffer in a 
water bath set at 85°C, for 30 minutes. Parafilm and lid were then removed, and the plate 
was left to cool at room temperature for 10 minutes. Sections were then washed three 
times of ten minutes’ intervals in 1x PBS. Hereafter, sections were incubated in blocking 
PBS-based buffer containing 0.5% Triton X-100 and 5% GS. Blocking buffer was replaced 
with the 1xPBS based solution including 0.3% Triton X- 100, 2.5% GS and the primary 
antibodies, anti-glutaminase and anti-GFP, and tissue was incubated at 4°C overnight. 
The second day, slices were washed three times for ten minutes in 1XPBS and were 
incubated overnight with the respective secondary antibodies diluted in 1xPBS solution 
with 1% GS. 
After washing at fifteen-minutes intervals, slices were incubated with primary antibody 
against RFP, in 1XPBS buffer with 0.3% Triton X-100 and 2.5% GS, overnight. Secondary 
antibody, AF594, along with the NT-435/455, diluted in 1xPBS buffer containing 1% GS, 
was applied after washing and left overnight for incubation. Finally, slices were washed 
three times with a minimum of fifteen minutes’ intervals. Tissue was mounted on slides 
and coverslipped using Vectashield mounting medium (Vector Laboratories) and stored 
at -20°C. 
In order to characterize as many cuneate nucleus projecting neurons as possible, the 
already stained and scanned slides from control, 3-weeks, and 12-weeks after injury 
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GlyT2 and GAD67 groups underwent a second histological analysis. Slides were 
unmounted carefully and placed in well plates. Heat-mediated antigen retrieval was 
performed as described above in order to remove all existing fluorescent signal and re-
stain for glutaminase. Following the antigen-retrieval, sections were washed three times 
of ten minutes’ intervals in 1x PBS and were incubated in blocking PBS- based buffer 
containing 0.5% Triton X-100 and 5% GS. Slices were then incubated overnight with the 
primary antibody for glutaminase in a 1xPBS based solution including 0.3% Triton X-100 
and 2.5% GS. The second day, slices were washed in 1XPBS and were incubated 
overnight with the respective secondary antibody AF488 diluted in 1xPBS solution with 
1% GS. Finally, slices were washed three times with minimum fifteen minutes’ intervals. 
Tissue was mounted on slides using Vectashield as mounting medium and stored at -
20°C. 
5. Imaging 
All images were acquired using automated confocal scanning of spinal cord tissue with 
the FV10-ASW microscopy software on an upright Olympus FV1000 confocal microscope 
system. Images were obtained using standard filter sets and acquisition settings were 
kept constant between control and post-injury groups for each experiment. To assess the 
density of spinal DRG collaterals four sections per animals were randomly chosen and for 
each section, four frames were scanned at 20 × magnification (objective: Olympus 
UPLSAPO 20XO, imaging medium: Olympus IMMOIL-F30CC, NA: 0.85; 640 × 640 pixels, 
zoom × 1.1, 0.45 µm z-resolution, 16bit). Image fields of view were positioned so that their 
medial borders aligned with the top of the spinal cord. At this magnification, all of white 
and gray matter was included, allowing the detection of all spinal DRG collaterals. 
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As described earlier, DRG axons were labeled with EYFP (AAV-EYFP), and cuneate 
nucleus-projecting neurons were labeled with RABV-mCherry. Images were acquired as 
stacks (tile scan acquisition) from 50μm thickness sections, using upright Leica SP8 WLL 
confocal microscope. 3 sections per antibody, per animal randomly chosen between C4 
and C6 cervical level were imaged. Sections were scanned at their right-half side, where 
the DRG sprouting axons were injected with the rAAV-CAG-EYFP. Image acquisition 
settings on the confocal were as follows: (i) scanning conducted in a sequential mode 
between frames with a x20/0.75 NA oil-immersion objective, (ii) resolution 2.048x2.048, 
(iii) frame average 4, (iv) step-size set to 1.5um and (v) zoom at 0.75. Any laser line could 
be generated by the microscope’s laser and the fluorescent signals were scanned in pairs 
using the Hybrid-Detectors (HyD). NeuroTrace 435/455 and mCherry were scanned 
together, EGFP with far-red (pseudocolored magenta) and EYFP alone. To avoid any 
overlap between the fluorescent signals the excitation and detection wavelengths were 
carefully set individually for each section, depending on the intensity of the signal. C57/Bl6 
mice images acquired with the same settings, but the fluorescent signals were different. 
GFP with AF488 was used for visualization of DRG sprouting axons as we have no 
transgene signal and RFP with AF 594 for cuneate nucleus projecting neurons. As a 
result, AF488 –sprouting collaterals- and AF647 -used for CGRP, PV or glutaminase 
staining- were scanned separately and NeuroTrace 435/455 was scanned simultaneously 
with AF594. Tiles were automatically stitched by the Leica Software. 
6. Image processing  
Images obtained with confocal microscopy (Leica SP8 and Olympus FV1000) and 
fluorescence microscope (DM4) were processed using ImageJ software to generate 
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maximum intensity projections. In order to obtain final images, the maximum intensity 
projections were processed in Adobe Photoshop using levels and gamma adjustments to 
enhance visibility of intermediate grey values. For visualizing the co-localization of 
cuneate nucleus projecting neurons and all staining/transgenic expression, both signals 
were pseudocolored before being overlaid using ImageJ software.  
7. Quantification 
a. Quantification of DRG sprouting 
To evaluate the sprouting of DRG axons, longitudinal sections of the spinal cord (50 µm 
thickness) were acquired with an Olympus FV1000 confocal microscope equipped with 
standard filter sets and a x20/0.85 objective. The number of collaterals was counted. The 
total number of DRG axons was calculated using the tubeness tool of ImageJ software 
averaging on three coronal sections for each spinal cord at cervical level 7. The number 
of collaterals per axon was then calculated. All quantifications were performed by an 
observer blinded with respect to injury status and time point. 
b. Quantification of the DRG axons localization 
To evaluate the localization of DRG axons following a sensory lesion, 15 coronal sections 
spanning the C3 to C6 area of the cervical spinal cord (50 µm thickness, every fifth 
section) were analyzed under a fluorescence microscope (Olympus IX71) with a x40/0.65 
air objective. The boutons were categorized as dorsal, intermediate, or ventral depending 
on their localization in the spinal cord (in layer I to IV: dorsal, V to VII: Intermediate and 
VIII to IX: ventral respectively). A bouton was defined as a thick varicosity along a 
comparably thin DRG axon in the cervical spinal cord. The number of boutons was 
expressed as percentage of all DRG axons boutons evaluated in the cervical spinal cord. 
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All quantifications were performed by an observer blinded with respect to injury status and 
time point. 
c. Quantification of the localization of cuneate nucleus projecting neurons  
To evaluate the localization of relay neurons following dorsal column lesion, every coronal 
section containing a cuneate nucleus labelled neuron (with the RABV) spanning the C3 to 
C6 area of the cervical spinal cord (50 µm thickness) were analyzed under a fluorescence 
microscope (Olympus IX71) with a x10/0.25 air objective. The neurons were categorized 
as dorsal, intermediate, or ventral depending on their localization in the spinal cord (in 
layer I to IV: dorsal, V to VII: intermediate and VIII to IX: ventral respectively). The number 
of neurons was expressed as percentage of all cuneate nucleus projecting neurons 
evaluated in the cervical spinal cord. All quantifications were performed by an observer 
blinded with respect to injury status and time point. 
d. Quantification of the number of contacted neurons and the number of 
contacts onto single neuron 
To evaluate the number of contacted neurons and the number of contacts onto single 
neurons, every coronal section containing a cuneate nucleus labelled neurons (with 
RABV) spanning the C3 to C6 area of the cervical spinal cord (50 µm thickness) were 
acquired with an Olympus FV1000 confocal microscope equipped with standard filter sets 
and a x20/0.85 oil immersion objective (zoom 1.5, step size 0.5 µm). All single planes from 
the image stacks were analyzed in order to assess the presence of a bouton (as described 
above) on a cuneate nucleus projecting neuron (dendrite/axon or cell body). Both values 
were normalized according to the number of labelled DRG fibers and cuneate nucleus 
projecting neurons. Briefly, the total number of DRG axons was calculated using the 
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tubeness tool of ImageJ software averaging on three coronal sections for each spinal cord 
at cervical level 7. The number of cuneate nucleus projecting neurons was normalized for 
efficiency by averaging the number of labelled neurons (with the RABV) in three coronal 
sections rostral to the lesion level (C2). The number of contacted neurons was expressed 
as percentage of the total number of cuneate nucleus projecting neurons between C3 and 
C6 of the spinal cord. The number of contacts onto single neuron was obtained by dividing 
the total number of contacts by the total number of contacted neurons. All quantifications 
were performed by an observer blinded with respect to injury status and time point. 
e. Quantification of the interneurons localization and subtype  
For all labelled neurons (mCherry, pseudocolored red, cuneate nucleus projecting 
neurons, transgenic GFP-positive, pseudocolored green, glycinergic or GABAergic 
neurons and far-red, pseudocolored magenta, CGRP or PV expressing neurons) except 
the glutamatergic ones, quantification was done on maximum intensity projections. Image 
stacks were first loaded on ImageJ and z-project/maximum intensity projection was 
generated. Using Adobe Photoshop and based on the Allen Brain Atlas- Mouse Spinal 
Cord Reference Atlas, the spinal cord was divided into dorsal (laminae I-IV), intermediate 
(laminae V-VII, X) and ventral (laminae VIII-IX) areas. The number of each interneuron 
subtype was counted for each area using the cell counter tool of ImageJ and all areas’ 
numbers for each subtype were added to give the sum. The number of single-, double- or 
triple-positive cuneate nucleus projecting neurons was counted separately in each spinal 
cord area. The total number was then calculated. Because of the high noise-to signal ratio 
for the glutaminase staining, it was very inaccurate to count the cell number on maximum 
intensity projections. For this purpose, in glutaminase stained sections counting was done 
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directly on the Image stacks and maximum projections were only used to separate the 
laminae into areas and for pointing the cells’ numbers using again the cell counter tool 
provided by ImageJ. 
In order to quantify the number of contacts onto interneurons all single planes from the 
image stacks were analyzed. A contact was defined as the presence of a bouton, a thick 
varicosity (about three time the diameter of a relatively thick DRG axon) (EYFP positive 
and pseudocolored yellow) closely apposed to an interneuron’s soma, dendrite, or axon. 
To facilitate counting for each subtype in each area (dorsal, intermediate, ventral) cell 
counter tool of ImageJ was used to point the contacts on the maximum intensity 
projections. Contacts for each subtype and area were given a different number. Moreover, 
contacts on single-, double- and triple-positive cuneate nucleus projecting neurons were 
separately counted using again different numbers for each area. For each category, 
numbers were summed to obtain the total number of contacts per condition for each 
section. 
8. Behavioral analysis 
The following behavioral tests were used to assess recovery after spinal cord injury (Deuis 
et al., 2017; Shelton et al., 2008) 
a. Forelimb placing response 
To assess proprioception, the visual placing test was used. In brief, the mouse is held 
suspended by the tail next to a table edge. The mouse is slowly advanced toward the 
edge of the table with its torso. A mouse without injury would extend its upper torso and 
paws simultaneously to reach the edge of the table. Prior to baseline, all mice underwent 
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three familiarization sessions. Following familiarization, each mouse is recorded and 
allowed to reach the edge three times. Each trial is then scored from 0 to 4 with (0) once 
aware of the edge, arches back and reaches out with both forepaws, (1) reach with both 
paws but uninjured paw leads, (2) does not reach occasionally with injured paw, (3) does 
not reach at all with injured paw, (4) head does not raise and does not reach with both 
paws. For each mouse, an average of the three score is calculated. 
b. “Baton” 
As a second proprioceptive test, the baton test was conducted. Briefly, the mouse is held 
suspended by the tail and allowed to grasp a 5-mm diameter stick with its forelimbs. After 
the mouse grasps the applicator, it is released while the mouse remains suspended. A 
mouse without injury would grasp the applicator with both forelimbs. Prior to baseline, all 
mice underwent three familiarization sessions. Following familiarization, each mouse is 
recorded and allowed to grasp the applicator three times. Each trial is then graded from 0 
to 4 with (0) grasp with both forelimbs, (1) grasp with both forelimbs but loses grasp with 
injured paw, (2) does not grasp occasionally with injured paw, (3) does not grasp 
frequently with injured paw, (4) does not grasp with injured paw at all. For each mouse, 
an average of the three score is calculated. 
c. The tail flick test 
As nociception test, the tail flick test was conducted. Briefly, the mouse is held in a tube 
closed on one end. Its tail is held without pressure between two fingers and immersed in 
a water bath at 50 degrees Celsius. The test is ended once the tail flicks. Prior to 
baseline no familiarization session is performed to prevent adaptative responses. Each 
mouse is recorded, and the tail immersed three times. Evaluation of the flick time is then 
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processed using the recorded videos. For each mouse, the average of the three times is 
calculated. 
 
9. Statistical evaluation 
All results are given as mean ± SEM. GraphPad Prism 7 for Windows (GraphPad 
software) was used to perform the statistical analysis. To compare two groups, student’s 
t-tests were used. In case of multiple comparison, a one-way ANOVA followed by a 
Tuckey post hoc test was performed. Significance levels are indicated as follow: * or # 
p<0.05; ** or ## p<0.01; *** or ### p<0.001. 
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Chapter 4 Results 
Each experiment of this chapter was performed following the same timeline, and mice 
were divided into three groups: control or unlesioned mice, 3 weeks, and 12 weeks 
timepoints. A unilateral dorsal column lesion was performed at level C2, one DRG at level 
C6 was labeled using an AAV expressing EGFP or EYFP (Figure 11a) and a pseudotyped 
rabies virus and complementary glycoprotein were injected in the cuneate nucleus in the 
medulla oblongata (Figure 11b). Tracers were always injected 10 days prior to sacrifice 
and following dissection, spinal cord were either cut longitudinally (to see the dorsal 
column from C2 to C6 regions) or coronally (to see the DRG sprouting in the gray matter) 
 
I. DRG neurons send new collaterals in the spinal cord 
Work from MD thesis from Julian Schwarting and Fabian Laage-Gaupp. 
Figure 11 Labeling of DRG cuneate nucleus neurons in mice. Picture of (a) a AAV-EYFP 
injection in an exposed spinal cord DRG at level C6 and (b) a mcherry rabies virus from a ventral 
approach. 
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For this experiment, mice were only labeled using the AAV-EGFP (Figure 12a). We could 
observe that even in an unlesioned animal, DRG axons send collaterals in the grey matter 
of the spinal cord (Figure 12b top). Nevertheless, following dorsal column lesion, DRG 
axons sprouts significantly already 3 weeks post injury (Figure 12b middle). After 12 
weeks, we noticed that this sprouting was reduced but still significantly increased 
compared to control (Figure 12b bottom). When quantified a 90% and 55% increase was 




Figure 12 DRG neurons send new collaterals in the spinal cord. (a) Timeline, lesion and 
injection site of the experiment and confocal picture of a DRG labeled using an AAV-EGFP (b) 
Confocal images of cervical DRG collaterals exiting into the grey matter in mice at 3 and 12 weeks 
post injury as well as control (c) Quantification of the number of collaterals exiting into the cervical 
grey matter (***: p<0.0001; *:p<0.01 n=10-17 mice per group) from (Granier et al., 2020) 
 
It was then questioned if this sprouting might target different areas of the spinal cord 
(dorsal, intermediate, or ventral layers). Therefore, the spinal cord sections labeled with 
AAV-EGFP were cut coronally, the number of varicosities were counted and a total 
number as well as a percentage of total varicosities was assessed (Figure 13a). 
It was first noticed that following injury, the total number of varicosities increased (Figure 
13b and c). We could see as well that in control mice, these varicosities were mostly in 
the intermediate and dorsal part of the spinal cord. But following injury a shift in dorsal 
sprouting was observed (Figure 13d). 
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These findings indicated that because of the injury, DRG axons sent new sprouting in the 
spinal cord to target new or existing neurons and therefore form a new circuit. 
Figure 13 DRG sprouting target different area of the spinal cord following injury. (a) 
Representative confocal image of the varicosities quantified on DRG axon collaterals (control 
animal). (b) Coronal confocal image of cervical DRG collaterals exiting into the grey matter in 
unlesioned (control) and lesioned mice at 3 and 12 post injury. Lines on the spinal cord represent 
the different areas analyzed (dorsal/intermediate and ventral). (c) Quantification of the normalized 
number of varicosities and their change following the lesion. (d) Localization of DRG varicosities 
in the ventral, intermediate and dorsal parts of the cervical spinal cord. Medial: *p<0.01. From 
(Granier et al, 2020) 
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Nevertheless, nothing is yet known about these new targets and if these varicosities are 
functional. To answer this question, some staining revealing either Basoon or Synapsin 
could be done. 
II. DRG neurons send collaterals in the spinal cord to contact cuneate 
nucleus neurons. 
For this experiment, mice were both labeled using the AAV-EYFP in the DRG at level C6 
and the mcherry rabies virus (Figure 14a). As it is known that DRG neurons project to the 
cuneate nucleus through the dorsal column lemniscal pathway, we thought that any 
contact made by these new DRG collaterals might be onto cuneate nucleus projecting 
neurons. In order to be sure of the specificity of the injection in the cuneate nucleus, control 
mice were injected with the rabies virus and its complementary glycoprotein. As it allows 
to see first order connection, the fluorescence will travel from the cuneate nucleus neurons 
to its pre-synaptic partner in the DRG. Therefore, successful injection will be noticeable 
through mcherry fluorescence in the DRG (Figure14b, arrow).  
First, the localization of these cuneate nucleus projecting neurons was assessed. We saw 
that in a control mouse, these neurons were mostly in the dorsal and intermediate layers 
of the spinal cord. Following lesion, already 3 weeks but even more 12 weeks post injury, 
most of the cuneate projecting neurons were localized in the intermediate layers (Figure 
14c). 
Through the double labeling, we were able to confirm contact formation between DRG 
axons and cuneate nucleus neurons, therefore validating the detour circuit hypothesis. 
 47 
Moreover, we could see that about 20% of all cuneate nucleus projecting neurons were 
contacted in a control situation. Three weeks following injury, this number increase 
significantly to 40% to decrease 12 weeks post injury (Figure 14d). We looked as well at 
the location of these contacted cuneate nucleus neurons and could confirm our previous 
results that they were mostly located in the intermediate and dorsal layers of the spinal 
cord (Figure 14e). Additionally, not only the total number of contacted cuneate neurons 
increased but as well the number of contacts per cuneate nucleus neuron (Figure 14f). To 
obtain this information, single plain analysis was performed: every coronal section 
containing a cuneate nucleus labelled neuron spanning the C3 to C6 area of the cervical 
spinal cord was acquired with a confocal microscope (step size 0.5 µm) and all single 
planes from the image stacks were analyzed (Figure 14g). We saw that even if the total 
number or cuneate nucleus neurons got reduced 12 weeks post injury, each neuron was 
significantly more contacted by DRG collaterals (Figure 14h). This could mean that the 
refinement happening between 3- and 12-weeks post lesion strengthened the valuable 
new connections, allowing the detour circuit to convey functional recovery. 
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Figure 14 DRG collaterals target cuneate nucleus projecting neurons. (a) Timeline, lesion and 
injection site of the experiment (b) Confocal picture of a spinal cord section labeled with an mcherry 
rabies virus (control mouse). (c) Quantification of the localization of cuneate nucleus projecting neurons 
in unlesioned (control) and lesioned mice at 3- and 12-weeks post injury. (d) Quantification of the 
localization of contacted cuneate nucleus projecting neurons in unlesioned (control) and lesioned mice 
at 3- and 12-weeks post injury. (* p<0.01 control vs 3 weeks (e) Quantifications of the localization of 
contacted cuneate nucleus projecting neurons in unlesioned (control) and lesioned mice at 3- and 12-
weeks post injury. (* p<0.01 control vs 12 weeks) (f) Quantifications of the number of contacts per 
cuneate nucleus neuron (** p<0.001 control vs 3weeks and *** p<0,0001 control vs 12 weeks) (g) 
Representative confocal images of appositions between cuneate nucleus projecting neurons and DRG 
collaterals in the cervical spinal cord (arrows point to appositions) (h) Representative confocal images 
of appositions between relay neurons and DRG collaterals. Quantification of the total number of 
contacts per timepoints. Data analyzed using 2-way ANOVA followed by Dunnett’s multiple 
comparisons test. Scale bars equal 300µm in (b), 50 µm in (g); right panel is a 3-times magnification of 
the boxed area) and 15 µm in (h). from (Granier et al., 2020) 
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In the event that these connections were functional synapses, the relay of sensory input 
could potentially be restored. 
III. New connections between DRG and cuneate nucleus allow 
proprioceptive recovery. 
To assess proprioceptive recovery two tests were performed: the forelimb placing 
response and the baton test (Shelton et al., 2008). The forelimb placing response is done 
with the mouse held suspended by the tail next to a table edge. The mouse is slowly 
advanced toward the edge of the table with its torso. A mouse without injury would extend 
its upper torso and paws simultaneously to reach the edge of the table. The baton test is 
done with the mouse held suspended by the tail and allowed to grasp a 5-mm diameter 
stick with its forelimbs. After the mouse grasps the applicator, it is released while the 
mouse remains suspended. A mouse without injury would grasp the applicator with both 
forelimbs. For both tests, following unilateral lesion, we will be able to differentiate 
between the unlesioned and the lesioned side. Each test will be scored between 0 and 2 
with 0 being both limbs extending/grabbing and 2 being no response from the injured paw. 
The timeline of these tests differs from the study of the detour circuit as a baseline and a 
post injury time point are necessary (Figure 15a). The forelimb placing test will assess 
recovery of proprioception, sensory input as well as coordination, the baton test for 
proprioception and coordination.  
The forelimb placing test showed an injury effect two days post lesion (Figure 15b, 
p<0.001 injured 2d vs injured baseline) as well as no significant difference between 
lesioned and unlesioned groups 12 weeks post lesion. Additionally, a significant difference 
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was observed between 12 weeks and 2 dpi (Figure 15b, p<0.05 12wks injured vs 2dpi 
injured). A weaker injury effect is observed for the baton test (Figure 15c, p<0.01 injured 
2d vs injured baseline) but contrarily to the forelimb placing response, this test showed 
significant improvement as early as 3 weeks post lesion (Figure 15c, p<0.05 and p<0.01 
3, 6, and 12wks injured vs 2dpi injured). 
Figure 15 Spontaneous proprioceptive recovery following dorsal column lesion. (a) Timeline 
of the dorsal column lesion paradigm and behavioral testing. (b) Picture of the forelimb pacing test 
and quantitative analysis of the scores obtained at baseline and different timepoints post dorsal 
column lesion. (c) Picture of the Baton test and quantitative analysis of the scores obtained at 
baseline and different timepoints post dorsal column lesion. Datasets were first tested for normality 
(non-normal distribution) and then analyzed using repeated nonparametric ANOVA (Friedmann 
test) followed by post-hoc multiple comparison Dunn’s tests. n=12-13 per group. *** p<0.001: 2dpi  
injured vs baseline injured, ** p<0.01: 2dpi  injured vs baseline injured. ## p<0.01: 12wks injured 
vs 2dpi injured, # p<0.05: 12wks injured vs 2dpi injured from (Granier et al., 2020) 
 51 
These findings showed that the detour circuit formed between the DRG and the cuneate 
nucleus allow the sensory and proprioceptive inputs to recover almost fully 12 weeks after 
the injury.  
The interneurons responsible for this spontaneous recovery are nevertheless not known.  
 
 
In order to look at nociception, the tail flick test was performed. In brief, mice were held in 
a tube and their tail was put in a warm water bath (temperature between 46 and 52 
degrees) until flicking. The timeline of this experiment (Figure 16a) differed from the 
sensory tests as it was shown mice tend to habituate when too often performed. The 
response time was used as readout (Figure 16b). We observed huge disparities between 
groups as well as between mice, but no significant difference was shown between 
Figure 16 Dorsal column lesion doesn’t induce nociception (a) Timeline of the dorsal column 
lesion paradigm and behavioral testing. (b) Quantitative analysis of the response time obtained at 
baseline and different timepoints post dorsal column lesion in the tail flick test. n=12-13 per group. 
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lesioned and unlesioned groups. These data are however to be taken carefully as the tail 
flick test was shown to be regulated by environmental parameters such as room humidity 
or animal’s body temperature. Nevertheless, no obvious aberrant pain was observed 
during the study. 
IV. Characterization of interneurons reveals increase contact onto 
parvalbumine and glycinergic neurons. 
Master thesis work from Angelina Fourli 
Because of the difference of localization of the DRG collaterals as well as the contacted 
cuneate nucleus neurons, we hypothesized that different types of interneurons might be 
recruited. One of the main challenges of this study was the combination of fluorescent 
dyes we had to use and the limitation of the confocal technology. Because of the AAV 
expressing EYFP and the rabies mcherry, we had to use the fluorescence still available: 
EGFP and far red. Luckily, two transgenic mice lines were available for us to use and were 
expressing EGFP in either glycinergic (GlyT2) or GABAergic cells (GAD). In order to label 
Parvalbumine (PV), a subtype of GABAergic cells, glutaminase, for excitatory neurons, 
and CGRP, a known neurotransmitter implicated in nociception, immunohistochemistry 
staining was performed. Parvalbumine neurons are known to be implicated in 
proprioception, making them a probable target of DRG collaterals (de Nooij et al, 2013). 
First, we looked at overall population of cuneate nucleus neurons and saw that all markers 
were expressed. The same observation was done in the population of contacted cuneate 
nucleus projecting neurons, even if CGRP and GAD positive cells were almost non-
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existent (Figure 18). Moreover, no significant change in these two neuronal populations 
was observed following dorsal column lesion. 
One of the questions we had following localization of the cuneate nucleus projecting 
neurons was whether a change in neuronal population might trigger the sprouting of the 
DRG collaterals. Therefore, we looked at the number of PV and GlyT2 positive neurons 
that were contacted post lesion and compared it the control group (Figure 17).  
First, we saw that in an unlesioned mouse, glutaminase positive neurons were more 
contacted than PV or GlyT2 positive ones (0,45 vs 0,2 and 0,18 respectively). Post lesion 
(3 or 12 weeks), no significant difference was observed. It should be noted that no change 
in glutaminase positive neurons was observed between control and lesioned animal 
(Figure 17a). We saw previously that following dorsal column lesion, a refinement between 
3 and 12 weeks happened. Nevertheless, no significant change in neuronal population 
was this time seen.  
The major changes were observed in PV and GlyT2 positive cells (Figure 17b and c). 
Following dorsal lesion, a three-fold increase in PV positive contacted neurons was 
detected, 3 weeks post lesion (2.5-fold 12 weeks post injury) and a 2.5-fold increase in 
GlyT2 positive cells (at both 3 and 12 weeks timepoints).  
As previously done, the number of contacts onto cuneate nucleus projecting neurons was 
assessed for each neuronal population. As per the number of contacted neurons, no 
significant change in number of contacts onto glutaminase positive neurons was 
observed. Similarly, to the number of PV positive contacted neurons, a significant increase 
in number of contacts was seen, in both 3- and 12-weeks groups (Figure17b, right).  
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One difference was nevertheless noticed: following dorsal column lesion, the number of 
contacts onto GlyT2 positive neurons significantly increase but was lost 12 weeks post 
lesion (Figure 17c, right). It should be however kept in mind that the total number of 
contacted GlyT2 positive neurons was in this group still significantly increased. 
The number of contacts onto CPRG and GAD positive neurons was close to non-existent 
as these two populations were barely contacted by DRG collaterals. 
Figure 17 Characterization of cuneate nucleus projecting neurons. Graphs indicating the 
percentage of cuneate nucleus projecting neurons positive for GAD and CGRP. 
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All these results showed us that following dorsal column lesion, DRG collaterals target 




parvalbumin neurons are known to be implicated in proprioception, making therefore this 
new circuit able to relay sensory and proprioceptive inputs back to the thalamus.  
If this new circuit is able to relay sensory inputs, does it keep its specificity and does it still 
run through the same pathway? 
V. The formation of a new circuit following dorsal lesion still rely on the 
dorsal medial lemniscus pathway 
One information was still missing after the validation of the formation of the detour circuit: 
is the dorsal medial lemniscus pathway responsible for the spontaneous recovery. 
Figure 18 Characterization of the nature of the cuneate nucleus relay projecting relay 
neurons. (a) Confocal images of cuneate nucleus neurons (red) double-labeled with markers for 
glutaminase (purple). Quantification of the % of cuneate nucleus projecting neurons 
immunoreactive for glutaminase contacted by DRG fibers (left) and quantification of the number 
of contacts onto glutaminase positive cuneate projecting neurons (right). (b) Confocal images of 
cuneate nucleus projecting neurons (red) double-labeled with markers for parvalbumin (purple). 
Quantification of the % of cuneate nucleus projecting neurons immunoreactive for parvalbumin 
contacted by DRG fibers (left) and quantification of the number of contacts onto parvalbumin 
positive cuneate projecting neurons (right). (c) Confocal images of cuneate nucleus projecting 
neurons (red) and transgenic labeling for glycinergic neurons (GlyT2: green). Quantification of the 
% of cuneate nucleus projecting neurons immunoreactive for glycine contacted by DRG fibers 
(left) and quantification of the number of contacts onto glycine positive cuneate projecting neurons 
(right). Areas boxed in the low magnification images are magnified 4 times in the left inset. All 
DRG fibers appear yellow on the pictures. Data were tested for normality and analyzed then with 
a one-way ANOVA followed by Dunnett’s post-hoc test. N = 9 sections per group and n = 3 animal 
per group. ***: p <0.0001, **: p < 0.001, * p<0.01. Scale bar equal 40 µm in (a–e). For insets scale 
bar equals 10 µm in (a–e). from (Granier et al., 2020) 
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In order to assess this question, we performed a relesion on mice 12 weeks post dorsal 
column lesion and performed again the behavioral tests (forelimb placing response and 
baton test). The unlesioned group was kept as control through this experiment (Figure 
19a). 
 
The new lesion was performed at level C6 just above the DRG where contact formation 
between collaterals and cuneate nucleus projecting neurons was seen. Following the 
relesion, both forelimb and baton test showed a lesion effect and a significant worsening 
of the score (Figure 19b and c). It should be noted that this new lesion effect did not reach 
the same level as the first lesion. 
These data led us to conclude on the implication of the dorsal medial lemniscus pathway 
in the detour circuit formation following a sensory lesion and its ability to restore 
proprioceptive inputs.  
Figure 19 Formation of the detour circuit mediates functional recovery. (a) Timeline of the 
dorsal column lesion paradigm and behavioral testing. (b) Picture of the forelimb pacing test and 
quantitative analysis of the scores obtained at 12 weeks as well as 2 days post relesion (c) Picture 
of the Baton test and quantitative analysis of the scores obtained at 12 weeks as well as 2 days 
post relesion. Datasets were first tested for normality (non-normal distribution) and then analyzed 
using a Kruskall-Wallis test followed by post-hoc multiple comparison Dunn’s tests ** p<0.001, * 
p<0.01. n=12 in the unlesioned group and 13 in the lesioned group. 
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Chapter 5 Discussion 
 
This study began after the detour circuit paradigm was found (Bareyre et al., 2004). 
Bareyre et al. observed that following thoracic hemisection, the corticospinal tract was 
able to spread collaterals in the ventral layers of the spinal cord to contact long 
propriospinal neurons which would then contact motor neurons in the lumbar spinal cord. 
Other studies followed, showing the same results, or studying the same paradigm in other 
tracts (Ahuja et al., 2017; Courtine et al., 2009; Gros et al., 2010). It was then hypothesized 
that the motor tracts were not the only ones who could remodel following injury. Moreover, 
motor recovery in spinal cord patients has been shown to be strongly correlated with 
sensory recovery. Additionally, Hollis II et al. showed plasticity of sensory axons (Hollis et 
al., 2015). This study tried therefore to elucidate if sensory tracts and axons remodel 
following injury, if reorganization of the tract implicate a new population of relay neurons 
and if the formation of a new detour circuit allows functional recovery. 
I. Study of the DRG sprouting following dorsal column lesion 
As a beginning for this study, only the response of DRG neurons following dorsal column 
lesion was assessed. The lesion was performed at cervical level 2 and was let 3 or 12 
weeks to recover. Ten days prior to sacrifice, an adeno-associated virus expressing EGFP 
was injected in the DRG at level cervical 6 to label the ascending tract.  
The results first showed a difference between the motor and sensory system. The dorsal 
column tract spreads collaterals in the grey matter of the spinal cord even unlesioned. It 
shows how versatile and adaptive the sensory system is and led to further elucidate this 
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hypothesis. We saw that following injury, the DRG neurons spread significantly more 
collaterals in the spinal cord, probably trying to counteract the loss of sensory input above 
the lesion. One interesting observation was the decrease of collaterals 12 weeks post 
lesion, resembling what happens in the motor system (Bareyre et al., 2004; Jacobi & 
Bareyre, 2015; Lang et al., 2012). This decrease can be seen as refinement of already 
formed connections where aberrant contacts are lost to those triggering functional 
recovery. 
We then looked more into detail at these collaterals and if their varicosities might spread 
differently after injury or even if the refinement 12 weeks post lesion might be the result of 
change of target. We saw that the number of varicosities in the intermediate layers of the 
spinal cord did not change after lesion but did increase significantly in ventral and dorsal 
layers at 3 and 12 weeks. Not only an increase in exiting collaterals was observed, but as 
well an increase in number of varicosities, hypothetically synapses, that could therefore 
contact neurons to regenerate the lost connections. 
Our conclusion was that following dorsal column lesion, the DRG axons are able to reroute 
their axons, spread more in the spinal cord and form more varicosities, in hope to find 
meaningful connections to restore the pathway. 
II. Study of the cuneate nucleus neurons and how they get contacted by 
DRG collaterals 
After we saw that DRG neurons were able to spread in the spinal cord following injury, we 
wanted to look more into detail at the neurons that were contacted by these collaterals. 
The dorsal column pathway travels from the DRG to the medulla oblongata to finally send 
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proprioceptive inputs in the thalamus (Kandel et al., 2000). The DRG neurons contact 
cuneate nucleus projecting neurons (their postsynaptic contacts) through two pathways. 
The first, through a direct connection to the cuneate nucleus, conveys about 80% of the 
overall sensory inputs. The second, through contact onto relay neurons which then contact 
cuneate nucleus neurons, relays about 20% of the inputs. 
In order to label cuneate nucleus projecting neurons, we used a pseudotyped rabies virus 
that allowed to only label first degree connections. Shortly, the rabies virus is cloned 
without its glycoprotein and can’t therefore travel through synapses (Mebatsion et al., 
1996). Once the rabies virus is complemented, it can travel retrogradely, making the 
fluorescence visible in the first-degree neurons. One advantage of this technique is the 
ability to follow where the rabies virus entered (because it will label the cell it first infected), 
where the G protein virus entered (because this virus can as well be marked with a 
fluorescent protein) and which neuron is contacting the primary cell. In our study, this 
allowed us to assess successful injection in the cuneate nucleus: when the rabies virus is 
injected with the G-protein, it will travel through the intact dorsal tract and label the DRG. 
After successful labeling of the cuneate nucleus projecting neurons, we wondered if any 
change in localization happened following injury, as we previously saw that DRG 
collaterals had more varicosities and were differently localized. We could see that 3 weeks 
and even stronger 12 weeks post injury, the cuneate nucleus projecting neurons were 
increased in the ventral layers of the spinal cord. Once these neurons were contacted by 
DRG collaterals, this difference was only true 12 weeks post lesion. Taking the overall 
population of cuneate nucleus projecting neurons, only 20% of them got contacted in a 
control mouse. After lesion, this number significantly increased to 40% but decreased 
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again 12 weeks post injury, probably resulting from a refinement of immature connections. 
Our ability to image simple plane in a spinal cord section allowed us to look at single 
contact between DRG collaterals and cuneate nucleus projecting neurons. Using this 
technique, we observed that both the total number of contact as well as the number of 
contacts per cuneate nucleus projecting neurons increase significantly 3 weeks post 
lesion and was sustained after 12 weeks. 
Our conclusion was that following injury, the DRG collaterals contact cuneate nucleus 
projecting neurons in order to restore the pathway. These collaterals will increase both 
the number of neurons as well as the number of contacts onto each of them, strengthening 
the valuable connections and establishing new ones to relay the sensory and 
proprioceptive inputs.  
III. Study of the functional recovery 
Functional recovery has always been the primary readout after spinal cord injury. When 
spared tissue is left to recover, and a new circuit is forming, one hope is that it will lead to 
functional recovery. In the motor system, it was shown in mice and rats that spontaneous 
rerouting of the CST lead to improvement on behavioral tests such as the catwalk and the 
ladder run (Jacobi & Bareyre, 2015; Loy et al., 2018; Metz & Whishaw, 2009). Other 
behavioral tests have been used to assess motor recovery: the treadmill, the reaching 
task and the BBB scale (Ahmed et al, 2019; Courtine et al., 2009). These tests look at 
both fine and gross motor skills and are able to show specific types of recovery. Following 
dorsal column lesion, other behavioral tests are required because no motor tracts have 
been damaged. In our study, we used the forelimb placing response, assessing recovery 
 62 
of proprioception, sensory input as well as coordination and the baton test for 
proprioception and coordination (Shelton et al., 2008).  
In our study, we showed that following dorsal column lesion, mice performed worse 2 days 
post injury and recover through time. This lesion effect can be explained as the injury 
shock and explain why mice already recover a lot at one week post lesion. In the forelimb 
placing test, we saw that mice recovered slowly until 12 weeks, where no significant 
difference with the unlesioned group was seen. In the baton test, this result could be seen 
already 3 weeks after injury. This difference could be explained by the fact that the baton 
test assesses for tactile input and proprioception whereas the forelimb placing test for 
forelimb coordination as well. Proprioceptive and sensory inputs are transmitted back to 
the cuneate nucleus through mature connections between DRG axons and cuneate 
nucleus projecting neurons. With the baton and forelimb placing tests, we show that 
already 3 weeks post-lesion, mice recover sensory and proprioceptive inputs, triggered 
by the formation of the detour circuit. 
One other aspect of sensory recovery still needs to be looked at: it is known that following 
spinal cord lesion, patients experience phantom pain, a phenomenon that up to now isn’t 
fully understood. This pain comes from nociceptive receptors that were injured during the 
lesion. Following dorsal column lesion, we asked ourselves if the same applied. We 
therefore performed the tail flick test, where the tail of a mouse is put in water with a 
constant temperature between 46°C and 52°C and the time until it flicks is recorded (each 
mouse is measured 3 times and the average of all time is taken). Multiple nociceptive tests 
are available, one of the most used, the von Frey test (Deuis et al., 2017). The rodent is 
placed in a closed cage with a mesh floor, the test consists in a single filament 
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perpendicularly applied to the plantar surface of the hind paw and left until the paw 
buckles. As previously stated, the tail flick test has been used in smaller settings to 
decrease the financial cost of such tests and might not, when studying complex pain 
mechanisms, be the most optimal. Others have been using this test in order to look, for 
example, at functional performances in rat following spinal cord injury (Pajoohesh-Ganji 
et al, 2010) and described too much variability to have a predictive value. Therefore, other 
tests, such as the CatWalk, are now being used to look at allodynia after spinal cord injury 
(Gabriel et al, 2009). In our case, its use allowed us to make sure that we didn’t exacerbate 
pain mechanism following dorsal column lesion.  
The tail flick test did not reveal any significant changes between the groups following 
dorsal column lesion. Nevertheless, the data should be taken with caution, as the 
spreading of the values is inconsistent within the same group and as unlesioned mice 
worsened their score in the middle of the study. This could be explained by external factors 
that influence this test, such as body temperature or even humidity level (Berge et al, 
1988; Lichtman et al, 1993).  
Our conclusion was that following dorsal column lesion, spontaneous and functional 
recovery is observed in mouse 3 weeks post injury. This recovery increases through time 
and shows that 12 weeks post injury, lesioned mice recover to the level of unlesioned 
mice in proprioception, coordination, and sensory input. 
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IV. Characterization of the relay neurons and the changes in contact of 
DRG collaterals 
The difference of localization of contacted nucleus projecting neurons led us think that 
different subtypes of relay neurons were contacted. In order to label these neurons, two 
methods were used: transgenic mice and immunohistochemistry. Transgenic mice lines 
present the advantage of being ready to use: once the tracer injected, the mice sacrificed 
and cut, the labeling is present. Nevertheless, one marker can be expressed by multiple 
cell types and might therefore overcrowd the picture. GlyT2-EGFP mice express a green 
fluorescent protein in all cells expressing glycine transporter 2 and are shown to be 
expressed in cells responsible for locomotion, respiration, or vocalization (Rousseau et al, 
2008; Zafra et al, 2017). GAD-EGFP mice express a green fluorescence in all cells 
expressing somatostatin (Todd, 2017). Somatostatin expressing neurons have been 
shown to be significant players in shaping activity and plasticity of the nervous system, 
therefore being of interest following spinal cord lesion (Liguz-Lecznar et al, 2016). These 
two markers allowed us to label inhibitory and excitatory neurons in the spinal cord. We 
then used immunohistochemistry to label other subtypes of relay neurons: parvalbumin 
for neurons implicated in proprioception, CGRP for nociception and glutaminase for 
excitatory neurons (Cangro et al, 1984; Neugebauer et al, 2009). 
We first saw that almost no DRG collaterals contacted neurons expressing CGRP, 
somehow confirming the result of the tail flick test, and showing no increase in pain related 
stimulus following dorsal column lesion. Additionally, close to no GAD positive cuneate 
nucleus projecting neurons were contacted. Interestingly, we found that DRG collaterals 
were mostly contacting glutaminase positive cuneate nucleus projecting neurons both in 
control and lesioned groups. Following dorsal column lesion, no significant change in 
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excitatory neurons recruitment was observed. The same observation was made for the 
number of contacts onto glutaminase expressing cuneate nucleus projecting neurons.  
On another side, following injury, a significant increase of parvalbumin expressing 
neurons was observed. Almost three times more neurons were contacted by DRG 
collaterals at both 3 and 12 weeks timepoints. It showed that the recovery observed in the 
forelimb placing and baton test might be the result of increase contact between DRG 
neurons and proprioceptive neurons. Moreover, the number of contacts onto PV positive 
cuneate nucleus projecting neurons was more than doubled 3 weeks post injury and 
sustained at 12 weeks. It shows that the connections established at 3 weeks post injury 
are strengthened through time in order to relay sensory and proprioceptive inputs. 
Moreover, Parvalbumine expressing neurons have been shown to have a critical role in 
inhibition of sensory threshold, therefore coordinating the activity of neuronal ensemble. 
Additionally, in an experiment specifically simulating Parvalbumine inhibitory neurons, 
Petitjean et al. showed a decrease of pain responses resulting from a prevention 
mechanism inactivating pain circuits. 
Neurons expressing glycine transporter 2 were as well significantly more contacted by 
DRG collaterals following injury. This 3-fold increase was observed 3- and 12-weeks post 
lesion and might show some level of neuronal excitability due to injury. It should be noted 
that glycinergic neurons control pain transmission as well in the dorsal spinal cord (Zafra 
et al., 2017). An increase in number of contacts was as well observed 3 weeks post lesion 
but not sustained after 12 weeks. This result could mean that the recruitment of GlyT2 
expressing neurons is necessary early after the injury but once the refinement over, they 
might not be as useful for recovery as parvalbumin expressing neurons. 
 66 
Our conclusion was that DRG collaterals target primarily glutaminase expressing neurons 
but following a dorsal column lesion, they recruit new relay neurons expressing 
parvalbumin, which are responsible for relaying proprioceptive inputs. 
V. Study of the implication of the dorsal column lemniscus pathway 
following recovery 
We showed that following dorsal column lesion, mice were able to recovery proprioception 
and sensory inputs 12 weeks post injury. DRG neurons and cuneate nucleus form part of 
the dorsal column pathway (Kandel et al., 2000) and are able to create a detour circuit 
following injury. The last question we had was whether following spinal reorganization, is 
the dorsal column pathway still relaying the sensory and proprioceptive inputs. In order to 
answer, a relesion experiment was conducted. Twelve weeks post injury, the lesioned 
mice were reopened, and a new dorsal column lesion was performed at cervical C6, where 
the DRG collaterals were previously contacting new relay neurons. We saw that after the 
relesion, mice in the injured group performed poorly the forelimb placing and baton tests. 
There was no significant difference between the score post lesion and post relesion even 
if the effect was to a lesser extent, showing that the new detour circuit formed was 
responsible for the functional recovery of proprioceptive and sensory input. 
This study was able to show that following dorsal column lesion, the DRG neurons were 
able to send collaterals to cuneate nucleus projecting neurons. These collaterals targeted 
parvalbumin expressing neurons, responsible for the relay of proprioceptive stimuli and 
allowed functional recovery 12 weeks post injury. The recovery of sensory inputs might 
be of great relevance for patients with incomplete spinal cord injury in order to trigger and 
enhance motor recovery.  
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Chapter 6 Conclusion 
 
In summary, I can conclude from this thesis: 
Following dorsal column lesion, DRG neurons are able to spread collaterals in the grey 
matter of the spinal cord and reach more predominantly the dorsal and ventral layers of 
the spinal cord. These collaterals are established already 3 weeks post injury, refined but 
sustained 12 weeks after lesion. These collaterals reach and contact cuneate nucleus 
projecting neurons in the dorsal and intermediate layers of the spinal cord in unlesioned 
mice and 3 weeks post injury and primarily in intermediate layers 12 weeks after lesion. A 
significant increase in number of contacted cuneate nucleus projecting neurons as well 
as contacts onto these neurons is observed. The formation of a detour circuit allows 
functional recovery and of proprioception, coordination, and sensory inputs 12 weeks after 
injury without eliciting aberrant pain. This detour circuit formation is mediated by contact 
between DRG collaterals and cuneate nucleus projecting neurons expressing 
parvalbumin and glycine transporter 2. The functional recovery can be lost again after re-
lesion of the tract above the previous injury. 
The dorsal medial lemniscus tract can, like motor tract, recover following spinal cord injury, 
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